Brief: BioVersys Announces BV100 Phase 3 Initiation And Provides Business Update
11/12/2025 11:58
Dec 11 (Reuters) - BioVersys AG BIOV.S: BIOVERSYS ANNOUNCES BV100 PHASE 3 INITIATION AND PROVIDES A BUSINESS UPDATE BIOVERSYS AG: IPO ADDED PROCEEDS OF CHF 76.7 MILLION Source text: ID:nGNX3pvQcb Further company coverage: BIOV.S ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioVersys AG
See all newsBrief: Bioversys Expects Total Operating Loss Of CHF 40-45 Mln For FY2026
RCS - Bio Versys AG - BioVersys and partners’
Brief: BioVersys Announces BV100 Phase 3 Initiation And Provides Business Update
Brief: Bioversys Says Patent Claims For Its BV100 Drug Candidate Have Been Granted In China
UBS, Stifel start coverage of BioVersys with 'buy;' shares climb